Search Results - "Watanabe, Rira"

Refine Results
  1. 1

    Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? by Kobayashi, Hisataka, Watanabe, Rira, Choyke, Peter L

    Published in Theranostics (01-01-2014)
    “…Nano-sized therapeutic agents have several advantages over low molecular weight agents such as a larger loading capacity, the ability to protect the payload…”
    Get full text
    Journal Article
  2. 2

    Cancer Drug Delivery: Considerations in the Rational Design of Nanosized Bioconjugates by Kobayashi, Hisataka, Turkbey, Baris, Watanabe, Rira, Choyke, Peter L

    Published in Bioconjugate chemistry (17-12-2014)
    “…In order to efficiently deliver anticancer agents to tumors, biocompatible nanoparticles or bioconjugates, including antibody–drug conjugates (ADCs), have…”
    Get full text
    Journal Article
  3. 3

    Near infrared photoimmunotherapy in the treatment of disseminated peritoneal ovarian cancer by Sato, Kazuhide, Hanaoka, Hirofumi, Watanabe, Rira, Nakajima, Takahito, Choyke, Peter L, Kobayashi, Hisataka

    Published in Molecular cancer therapeutics (01-01-2015)
    “…Near infrared photoimmunotherapy (NIR-PIT) is a new cancer treatment that combines the specificity of intravenously injected antibodies for targeting tumors…”
    Get full text
    Journal Article
  4. 4

    Photoimmunotherapy targeting prostate-specific membrane antigen: are antibody fragments as effective as antibodies? by Watanabe, Rira, Hanaoka, Hirofumi, Sato, Kazuhide, Nagaya, Tadanobu, Harada, Toshiko, Mitsunaga, Makoto, Kim, Insook, Paik, Chang H, Wu, Anna M, Choyke, Peter L, Kobayashi, Hisataka

    Published in Journal of Nuclear Medicine (01-01-2015)
    “…Photoimmunotherapy is a highly cell-selective cancer therapy based on an armed antibody conjugate with a phthalocyanine-based photosensitizer, IR700…”
    Get full text
    Journal Article
  5. 5

    Comparative effectiveness of light emitting diodes (LEDs) and Lasers in near infrared photoimmunotherapy by Sato, Kazuhide, Watanabe, Rira, Hanaoka, Hirofumi, Nakajima, Takahito, Choyke, Peter L, Kobayashi, Hisataka

    Published in Oncotarget (22-03-2016)
    “…Near infrared photoimmunotherapy (NIR-PIT) is a new cancer treatment that combines the specificity of antibodies for targeting tumors with the toxicity induced…”
    Get full text
    Journal Article
  6. 6

    Glypican‑3 Targeted Human Heavy Chain Antibody as a Drug Carrier for Hepatocellular Carcinoma Therapy by Hanaoka, Hirofumi, Nagaya, Tadanobu, Sato, Kazuhide, Nakamura, Yuko, Watanabe, Rira, Harada, Toshiko, Gao, Wei, Feng, Mingqian, Phung, Yen, Kim, Insook, Paik, Chang H, Choyke, Peter L, Ho, Mitchell, Kobayashi, Hisataka

    Published in Molecular pharmaceutics (01-06-2015)
    “…Glypican-3 (GPC3) represents an attractive target for hepatocellular carcinoma (HCC) therapy because it is highly expressed in HCC but not in adult normal…”
    Get full text
    Journal Article
  7. 7

    Photoimmunotherapy: Comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor by Sato, Kazuhide, Watanabe, Rira, Hanaoka, Hirofumi, Harada, Toshiko, Nakajima, Takahito, Kim, Insook, Paik, Chang H., Choyke, Peter L., Kobayashi, Hisataka

    Published in Molecular oncology (01-05-2014)
    “…Photoimmunotherapy (PIT) is a new cancer treatment that combines the specificity of antibodies for targeting tumors with the toxicity induced by…”
    Get full text
    Journal Article
  8. 8

    The effects of conjugate and light dose on photo-immunotherapy induced cytotoxicity by Nakajima, Takahito, Sato, Kazuhide, Hanaoka, Hirofumi, Watanabe, Rira, Harada, Toshiko, Choyke, Peter L, Kobayashi, Hisataka

    Published in BMC cancer (30-05-2014)
    “…Photoimmunotherapy (PIT) is a highly cell-selective cancer therapy, which employs monoclonal antibodies conjugated to a potent photosensitizer (mAb-IR700)…”
    Get full text
    Journal Article
  9. 9

    Real-time monitoring of hemodynamic changes in tumor vessels during photoimmunotherapy using optical coherence tomography by Liang, Chia-Pin, Nakajima, Takahito, Watanabe, Rira, Sato, Kazuhide, Choyke, Peter L, Chen, Yu, Kobayashi, Hisataka

    Published in Journal of biomedical optics (01-09-2014)
    “…Photoimmunotherapy (PIT) is a cell-specific cancer therapy based on an armed antibody conjugate that induces rapid and highly selective cancer cell necrosis…”
    Get full text
    Journal Article
  10. 10

    Minibody-Indocyanine Green Based Activatable Optical Imaging Probes: The Role of Short Polyethylene Glycol Linkers by Watanabe, Rira, Sato, Kazuhide, Hanaoka, Hirofumi, Harada, Toshiko, Nakajima, Takahito, Kim, Insook, Paik, Chang H, Wu, Anna M, Choyke, Peter L, Kobayashi, Hisataka

    Published in ACS medicinal chemistry letters (10-04-2014)
    “…Minibodies show rapider blood clearance than IgGs due to smaller size that improves target-to-background ratio (TBR) in in vivo imaging. Additionally, the…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Fluorescence‐lifetime molecular imaging can detect invisible peritoneal ovarian tumors in bloody ascites by Nakajima, Takahito, Sano, Kohei, Sato, Kazuhide, Watanabe, Rira, Harada, Toshiko, Hanaoka, Hirofumi, Choyke, Peter L., Kobayashi, Hisataka

    Published in Cancer science (01-03-2014)
    “…Blood contamination, such as bloody ascites or hemorrhages during surgery, is a potential hazard for clinical application of fluorescence imaging. In order to…”
    Get full text
    Journal Article
  13. 13

    Characterization of Tumor Imaging with Microbubble-Based Ultrasound Contrast Agent, Sonazoid, in Rabbit Liver by Watanabe, Rira, Matsumura, Manabu, Chen, Chun-Jen, Kaneda, Yuki, Fujimaki, Masayoshi

    Published in Biological & pharmaceutical bulletin (01-06-2005)
    “…In order to investigate improvement of hepatic tumor detectability by Sonazoid with phase inversion imaging, the contrast effects on the liver of metastatic…”
    Get full text
    Journal Article
  14. 14

    Gray-Scale Liver Enhancement with Sonazoid (NC100100), a Novel Ultrasound Contrast Agent; Detection of Hepatic Tumors in a Rabbit Model by Watanabe, Rira, Matsumura, Manabu, Chen, Chun-Jen, Kaneda, Yuki, Ishihara, Masanao, Fujimaki, Masayoshi

    Published in Biological & pharmaceutical bulletin (01-09-2003)
    “…The liver contrast effects of Sonazoid in two ultrasonographic imaging modes, gray-scale conventional and harmonic, were examined as a time-related study in…”
    Get full text
    Journal Article
  15. 15

    Acoustic Cluster Therapy (ACT) – A novel concept for ultrasound mediated, targeted drug delivery by Sontum, Per, Kvåle, Svein, Healey, Andrew John, Skurtveit, Roald, Watanabe, Rira, Matsumura, Manabu, Østensen, Jonny

    Published in International journal of pharmaceutics (30-11-2015)
    “…[Display omitted] A novel approach for ultrasound (US) mediated drug delivery – Acoustic Cluster Therapy (ACT) – is proposed, and basic characteristics of the…”
    Get full text
    Journal Article
  16. 16

    Contrast-Enhanced Ultrasound with Perflubutane in the Assessment of Anti-Angiogenic Effects: Early Prediction of the Anticancer Activity of Bevacizumab in a Mouse Xenografted Model by Watanabe, Rira, Munemasa, Toshiko, Matsumura, Manabu

    Published in Ultrasound in medicine & biology (01-09-2015)
    “…Abstract To investigate the feasibility of contrast-enhanced ultrasound (CEUS) with perflubutane for evaluating anti-angiogenic effects, we assessed the…”
    Get full text
    Journal Article
  17. 17

    Mechanism of Hepatic Parenchyma-Specific Contrast of Microbubble-Based Contrast Agent for Ultrasonography: Microscopic Studies in Rat Liver by Watanabe, Rira, Matsumura, Manabu, Munemasa, Toshiko, Fujimaki, Masayoshi, Suematsu, Makoto

    Published in Investigative radiology (01-09-2007)
    “…OBJECTIVE:The objective of this study was to elucidate the mechanism of hepatic parenchyma-specific contrast of Sonazoid (microbubble contrast agent) using…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Photoimmunotherapy of hepatocellular carcinoma-targeting Glypican-3 combined with nanosized albumin-bound paclitaxel by Hanaoka, Hirofumi, Nakajima, Takahito, Sato, Kazuhide, Watanabe, Rira, Phung, Yen, Gao, Wei, Harada, Toshiko, Kim, Insook, Paik, Chang H, Choyke, Peter L, Ho, Mitchell, Kobayashi, Hisataka

    Published in Nanomedicine (London, England) (01-04-2015)
    “…Effectiveness of Glypican-3 (GPC3)-targeted photoimmunotherapy (PIT) combined with the nanoparticle albumin-bound paclitaxel (nab-paclitaxel) for…”
    Get full text
    Journal Article
  20. 20